Skip menu navigation Home > Listing of Viewable PTMT Reports > Table of Contents for This Set of Reports


U.S. PATENT AND TRADEMARK OFFICE
Patent Technology Monitoring Team (PTMT)

Patenting In Technology Classes,
Breakout By Organization

Count of 2010 - 2014 Utility Patent Grants,
By Calendar Year of Grant
With Patent Counts Based on Primary Patent Classification

- Explanation of Data -

Rank Ordered Listing of Organizations Receiving 5 or More Utility Patents During the Period
Having Primary Classification In

Class 530, Chemistry: Natural Resins or Derivatives; Peptides or Proteins; Lignins or Reaction Products Thereof

( technology class is determined by the primary classification assigned to the patent- see 'Explanation of Data' )
( patent ownership is determined by the first-named assignee listed on a patent )

The following table displays first-named assignees and counts of their associated patents, as distributed by the year of patent grant.
First-Named Assignee 2010 2011 2012 2013 2014 Total
~INDIVIDUALLY OWNED PATENT 32 27 27 22 18 126
GENENTECH, INC. 36 18 11 20 17 102
AMGEN, INC. 23 16 12 9 10 70
UNIVERSITY OF CALIFORNIA, THE REGENTS OF 14 6 12 13 11 56
UNITED STATES OF AMERICA, DEPARTMENT OF HEALTH & HUMAN SERVICES 8 12 2 8 8 38
ZYMOGENETICS, INC. 11 6 7 6 4 34
BAXTER INTERNATIONAL INC. 1 14 3 5 10 33
XENCOR, INC. 4 4 10 6 7 31
CHUGAI SEIYAKU KABUSHIKI KAISHA 6 9 4 5 5 29
WISCONSIN ALUMNI RESEARCH FOUNDATION 6 3 3 7 10 29
SCHERING CORP. 7 15 6 0 0 28
E. I. DU PONT DE NEMOURS AND COMPANY 7 10 2 5 3 27
AGENSYS, INC. 6 11 3 4 1 25
HOFFMANN-LA ROCHE INC. 0 4 6 4 11 25
NOVARTIS AG (FORMERLY SANDOZ LTD.) 3 5 9 4 4 25
NOVO NORDISK A/S 2 4 5 4 10 25
BRISTOL-MYERS SQUIBB COMPANY 10 5 4 2 3 24
STANFORD UNIVERSITY 5 5 5 4 5 24
UNIVERSITY OF TEXAS 6 5 4 2 6 23
KYOWA HAKKO KIRIN CO., LTD. 2 7 5 6 2 22
AMBRX, INC. 1 5 7 3 5 21
MEDAREX, INC. 3 4 7 6 0 20
ALLERGAN, INC. 9 5 3 1 1 19
MERCK SHARP & DOHME CORP. 1 2 3 7 6 19
ABBVIE INC. 0 0 0 3 15 18
BIOGEN IDEC MA INC. 3 9 2 1 3 18
HUMAN GENOME SCIENCES, INC. 4 6 5 2 0 17
IMMUNEX CORPORATION 6 6 1 2 1 16
IMMUNOMEDICS INC. 1 5 2 3 5 16
LUDWIG INSTITUTE FOR CANCER RESEARCH 7 7 2 0 0 16
NEKTAR THERAPEUTICS 2 2 5 6 1 16
ONCOTHERAPY SCIENCE, INCORPORATED 3 3 0 5 5 16
SENOMYX, INC. 6 6 2 2 0 16
ABBOTT LABORATORIES 2 5 5 2 1 15
PIONEER HI-BRED INTERNATIONAL, INC. 5 5 1 3 1 15
SCRIPPS RESEARCH INSTITUTE 4 4 4 1 2 15
ELI LILLY AND COMPANY 3 4 5 1 1 14
TUFTS UNIVERSITY 3 3 1 4 3 14
WYETH 4 5 2 2 1 14
YEDA RESEARCH AND DEVELOPMENT CO., LTD. 3 3 2 5 1 14
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS 1 4 2 4 2 13
DANA-FARBER CANCER INSTITUTE, INC. 7 2 2 1 1 13
DANISCO US INC 2 3 2 2 4 13
MACROGENICS, INC. 4 2 3 2 2 13
NOVO NORDISK HEALTH CARE AG 2 2 1 3 5 13
UNIVERSITY OF ILLINOIS 3 3 2 3 2 13
BIO-RAD LABORATORIES, INC. 2 3 3 1 3 12
IMMATICS BIOTECHNOLOGIES GMBH 2 4 4 2 0 12
IMMUNOGEN INC. 1 3 3 2 3 12
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE 1 0 2 6 3 12
MASSACHUSETTS INSTITUTE OF TECHNOLOGY 0 3 1 4 4 12
MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH 3 3 1 3 2 12
MEDIMMUNE, LLC 4 2 2 1 3 12
MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG 1 3 2 1 5 12
RAMOT AT TEL AVIV UNIVERSITY LTD. 1 2 5 4 0 12
UNIVERSITY OF PENNSYLVANIA 3 4 1 1 3 12
GE HEALTHCARE BIO-SCIENCES AB 3 0 3 1 4 11
JAPAN SCIENCE AND TECHNOLOGY AGENCY 2 5 0 2 2 11
JOHNS HOPKINS UNIVERSITY 2 3 3 1 2 11
UNITED STATES OF AMERICA, DEPARTMENT OF AGRICULTURE 1 4 2 2 2 11
UNIVERSITY OF MINNESOTA, THE REGENTS OF 3 2 2 3 1 11
ACADEMIA SINICA 2 0 3 3 2 10
CRUCELL HOLLAND, B.V. 4 1 5 0 0 10
GLAXO GROUP LIMITED 2 1 3 1 3 10
INSTITUT PASTEUR 5 0 2 0 3 10
INTREXON CORPORATION 2 2 2 1 3 10
MILLENNIUM PHARMACEUTICALS, INC. 5 2 1 0 2 10
SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE 1 5 3 1 0 10
UCB PHARMA S.A. 1 3 1 3 2 10
AMYLIN PHARMACEUTICALS, INC. 4 2 1 2 0 9
ARES-TRADING S.A. 4 1 2 2 0 9
EMD MILLIPORE CORPORATION 0 0 3 4 2 9
INVENTION SCIENCE FUND I, LLC 2 6 0 0 1 9
ISIS INNOVATION LIMITED 3 2 2 1 1 9
YALE UNIVERSITY 2 3 2 1 1 9
BRIGHAM AND WOMEN'S HOSPITAL, INC. 2 3 1 2 0 8
CELL SIGNALING TECHNOLOGY, INC. 1 6 0 1 0 8
DSM IP ASSETS B.V. 1 1 1 2 3 8
DUKE UNIVERSITY 1 2 0 3 2 8
DYAX CORP. 1 3 2 0 2 8
FLORIDA STATE UNIVERSITY 3 0 4 0 1 8
GENERAL HOSPITAL CORPORATION 2 2 1 1 2 8
HELIAE DEVELOPMENT, LLC 0 0 0 5 3 8
IMMUNOCORE LIMITED 0 2 3 3 0 8
RIKEN 1 2 1 3 1 8
UNIVERSITY OF ARKANSAS 1 1 3 2 1 8
UNIVERSITY OF MASSACHUSETTS 3 2 2 1 0 8
UNIVERSITY OF ROCHESTER 2 1 2 2 1 8
AVEO PHARMACEUTICALS, INC. 2 0 0 4 1 7
CHILDREN'S MEDICAL CENTER CORPORATION 2 0 1 0 4 7
COLUMBIA UNIVERSITY 2 2 1 2 0 7
CSL LIMITED 1 0 2 3 1 7
FIVE PRIME THERAPEUTICS, INC. 2 2 1 2 0 7
LIFE TECHNOLOGIES CORPORATION 0 1 0 5 1 7
MEDIMMUNE LIMITED 0 3 1 2 1 7
NATIONAL RESEARCH COUNCIL OF CANADA 1 3 0 2 1 7
NEW YORK UNIVERSITY 3 1 1 1 1 7
NOVIMMUNE SA 3 0 2 2 0 7
ONCOMED PHARMACEUTICALS, INC. 2 1 2 1 1 7
PALATIN TECHNOLOGIES, INC. 1 1 1 2 2 7
PANASONIC CORPORATION 1 1 0 0 5 7
PHILOGEN S.P.A. 1 1 1 3 1 7
REGENERON PHARMACEUTICALS, INC. 1 2 1 1 2 7
ROCKEFELLER UNIVERSITY 1 1 1 3 1 7
SALADAX BIOMEDICAL INC. 1 2 2 2 0 7
TAKEDA PHARMACEUTICAL COMPANY LIMITED 4 0 0 2 1 7
UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION 4 0 2 0 1 7
UNIVERSITY OF MARYLAND 4 0 1 0 2 7
ABLYNX N.V. 0 0 2 1 3 6
AFFINERGY, INC. 4 2 0 0 0 6
AJINOMOTO COMPANY INCORPORATED 1 0 0 2 3 6
AMGEN FREMONT INC. 4 0 1 0 1 6
AMSILK GMBH 1 3 0 0 2 6
APOGENIX GMBH 0 0 0 3 3 6
BIOCON LIMITED 0 4 0 1 1 6
BIOMERIEUX SA 1 1 1 2 1 6
BOLDER BIOTECHNOLOGY, INC. 3 0 2 1 0 6
CASE WESTERN RESERVE UNIVERSITY 0 1 2 0 3 6
CEM CORPORATION 0 2 2 1 1 6
CENTOCOR ORTHO BIOTECH INC. 0 1 3 2 0 6
CENTOCOR, INC. 2 2 2 0 0 6
CENTRE FOR ADDICTION AND MENTAL HEALTH 0 0 2 2 2 6
CITY OF HOPE 1 0 1 1 3 6
COMPUGEN LTD. 3 2 0 1 0 6
DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS 1 1 2 2 0 6
DOW AGROSCIENCES LLC 2 2 2 0 0 6
ESBATECH, AN ALCON BIOMEDICAL RESEARCH UNIT, LLC 0 1 0 3 2 6
FUJIFILM CORPORATION 1 1 1 3 0 6
GENERAL ELECTRIC COMPANY 1 2 1 1 1 6
GENZYME CORPORATION 1 0 1 2 2 6
IDEXX LABORATORIES, INC. 1 0 3 2 0 6
INCYTE CORPORATION 0 2 0 1 3 6
JANSSEN ALZHEIMER IMMUNOTHERAPY 3 1 0 2 0 6
JANSSEN BIOTECH, INC. 0 0 0 3 3 6
JNC CORPORATION 0 0 0 1 5 6
LPATH INC. 1 2 1 1 1 6
MERCK SERONO SA 3 1 0 1 1 6
MORPHOTEK, INC. 2 0 1 2 1 6
NOVARTIS VACCINES AND DIAGNOSTICS, INC. 2 3 1 0 0 6
NOVOZYMES A/S 0 1 2 1 2 6
OTSUKA PHARMACEUTICAL CO., LTD. 3 1 1 0 1 6
PIERRE FABRE MEDICAMENT 0 1 1 1 3 6
RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK 4 0 0 1 1 6
ROCHE DIAGNOSTICS OPERATIONS, INC. 4 2 0 0 0 6
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH 1 3 1 0 1 6
STOWERS INSTITUTE FOR MEDICAL RESEARCH 0 1 2 2 1 6
SYNERGY PHARMACEUTICALS, INC. 1 0 1 3 1 6
THERAVANCE, INC. 3 2 1 0 0 6
UNIVERSITY OF COLORADO, THE REGENTS OF 1 0 1 0 4 6
UNIVERSITY OF IOWA RESEARCH FOUNDATION 1 0 2 1 2 6
UNIVERSITY OF UTAH RESEARCH FOUNDATION 1 0 1 3 1 6
WASHINGTON UNIVERSITY 1 0 2 3 0 6
ABBVIE BIOTHERAPEUTICS INC. 0 0 0 3 2 5
AILERON THERAPEUTICS, INC. 0 3 0 1 1 5
B.R.A.H.M.S GMBH 0 1 0 3 1 5
BAROFOLD, INC. 2 0 1 0 2 5
BAYER HEALTHCARE, LLC 3 0 1 0 1 5
CALIFORNIA INSTITUTE OF TECHNOLOGY 1 0 1 1 2 5
CORIXA CORPORATION 1 3 1 0 0 5
CSL BEHRING GMBH 0 1 0 1 3 5
DAIICHI SANKYO COMPANY, LIMITED 0 0 1 3 1 5
FUJIFILM MANUFACTURING EUROPE B.V. 0 2 3 0 0 5
FUSO PHARMACEUTICAL INDUSTRIES, LTD. 0 2 0 3 0 5
GENETICS INSTITUTE, INC. 3 2 0 0 0 5
HARVARD COLLEGE, PRESIDENT AND FELLOWS 2 0 1 1 1 5
INTERNATIONAL INSTITUTE OF CANCER IMMUNOLOGY, INC. 2 1 0 1 1 5
IPSEN PHARMA S.A.S. 0 1 2 1 1 5
ISP INVESTMENTS INC. 0 0 1 3 1 5
JANSSEN PHARMACEUTICA N.V. 1 2 2 0 0 5
JURIDICAL FOUNDATION, THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE 1 1 3 0 0 5
MEDAREX, L.L.C. 0 0 0 1 4 5
MOCHIDA PHARMACEUTICAL CO., LTD. 0 1 2 2 0 5
MOMENTA PHARMACEUTICALS, INC. 0 1 1 0 3 5
NORTHWESTERN UNIVERSITY 0 0 1 1 3 5
OCTAPHARMA AG 1 1 1 1 1 5
PFIZER INC. 0 1 2 1 1 5
PIERIS AG 2 1 1 1 0 5
ROCHE GLYCART AG 0 0 0 1 4 5
SANDOZ AG 0 1 1 2 1 5
SEATTLE GENETICS, INC. 1 2 0 1 1 5
SIEMENS HEALTHCARE DIAGNOSTICS INC. 2 2 0 0 1 5
SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH 2 0 1 0 2 5
SPIBER TECHNOLOGIES AB 0 0 2 1 2 5
TEXAS A AND M UNIVERSITY 4 0 0 1 0 5
UAB RESEARCH FOUNDATION 0 2 0 0 3 5
UNIVERSITY OF DELAWARE 1 3 0 1 0 5
UNIVERSITY OF SOUTH FLORIDA 3 0 0 1 1 5
UNIVERSITY OF SOUTHERN CALIFORNIA 1 2 0 2 0 5
VERTEX PHARMACEUTICALS, INC. 1 1 1 1 1 5



PTMT Contacts

Questions regarding these reports should be directed to:

U.S. Patent and Trademark Office
Electronic Information Products Division - PTMT
P.O Box 1450
Alexandria VA 22313-1450

tel: (571) 272-5600
fax: (571) 273-0110
email: oeip@uspto.gov

address of PTMT pages at the USPTO Web Site: http://www.uspto.gov/web/offices/ac/ido/oeip/taf/reports.htm
selected PTMT files available for download at : http://www.uspto.gov/web/offices/ac/ido/oeip/taf/data/


Top

Skip menu navigation Home > Listing of Viewable PTMT Reports > Table of Contents for This Set of Reports